Bloomberg analysts Eric Balchunas and James Seyffart, Litecoin $118.7 and predicts that Hedera ETFs could launch before Solana and XRP ETFs. Analysts made evaluations on the factors that support these expectations in the crypto ETF market.
Litecoin and Hedera ETFs
Eric Balchunas stated in his X platform post that his team predicts that Litecoin and Hedera ETFs will be approved before Solana and XRP ETFs. The analyst stated that they expect a wave of crypto ETFs next year, but it will not happen at the same time.
James Seyffart explained that the approval of Solana and XRP ETFs should be handled by the SEC’s new administration, and in the process, complex legal issues regarding the security status of these cryptocurrencies should be resolved.
James Seyffart: “Legal issues must be resolved first for the approval of Solana and XRP ETFs.”
Legal Issues and Prospects
In the case of XRP, Ripple $2.6‘s ongoing lawsuit with the SEC has still not been resolved. This process makes it less likely that Solana and XRP ETFs will be approved. In contrast, it was stated that Litecoin and Hedera are not considered securities by the SEC.
Canary Capital is the only asset manager to apply for Litecoin and Hedera ETFs, leading to assessments that the demand for these crypto products is not sufficient. On the other hand, companies such as Bitwise, 21Shares and WisdomTree have applied for XRP ETFs; Grayscale, VanEck and Bitwise are continuing their applications for Solana ETFs.
Analysts stated that although Litecoin and Hedera ETFs are more likely to be approved, the demand for these funds will be decisive.
Overall, it has been observed that different dynamics operate in the crypto ETF market and legal challenges may affect the processes. It is important for investors to follow the approval processes of ETFs and consider the legal status of cryptocurrencies.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that crypto currencies carry high volatility and therefore risk, and should carry out their transactions in line with their own research.